188 related articles for article (PubMed ID: 16465525)
1. [Microarrays for the identification of molecular markers in the diagnosis and therapy of renal cell carcinomas].
Sültmann H; Poustka A
Urologe A; 2006 Mar; 45(3):297-8, 300-4. PubMed ID: 16465525
[TBL] [Abstract][Full Text] [Related]
2. [Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma].
Merseburger AS; Hennenlotter J; Schilling D; Sievert KD; Küfer R; Kuczyk MA
Urologe A; 2006 Mar; 45(3):323-4, 326-7. PubMed ID: 16465523
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of renal cell carcinoma and clinical implications.
Rogers CG; Tan MH; Teh BT
Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028
[No Abstract] [Full Text] [Related]
4. [Introduction to the topic: molecular biological elucidation of renal cell carcinoma].
Küfer R; Hautmann R
Urologe A; 2006 Mar; 45(3):295-6. PubMed ID: 16482464
[No Abstract] [Full Text] [Related]
5. Molecular profiling of renal cancer: the journey to clinical application.
Ribal MJ
Eur Urol; 2011 May; 59(5):731-3. PubMed ID: 21296486
[No Abstract] [Full Text] [Related]
6. Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications.
Li M; Wang Y; Cheng L; Niu W; Zhao G; Raju JK; Huo J; Wu B; Yin B; Song Y; Bu R
Oncotarget; 2017 Jul; 8(29):48424-48435. PubMed ID: 28467794
[TBL] [Abstract][Full Text] [Related]
7. Genetics in renal cell carcinoma.
Dal Cin P
Curr Opin Urol; 2003 Nov; 13(6):463-6. PubMed ID: 14560139
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics.
Takahashi M; Sugimura J; Yang X; Vogelzang N; Teh BS; Furge K; Teh BT
Adv Cancer Res; 2003; 89():157-81. PubMed ID: 14587873
[TBL] [Abstract][Full Text] [Related]
9. [Identification of biomarkers and therapeutic targets for renal cell cancer using ProteinChip technology].
Junker K; von Eggeling F; Müller J; Steiner T; Schubert J
Urologe A; 2006 Mar; 45(3):305-6, 308, 310-12 passim. PubMed ID: 16491405
[TBL] [Abstract][Full Text] [Related]
10. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
Slabý O; Svoboda M; Michálek J; Vyzula R
Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
[TBL] [Abstract][Full Text] [Related]
11. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
[TBL] [Abstract][Full Text] [Related]
13. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival.
Sültmann H; von Heydebreck A; Huber W; Kuner R; Buness A; Vogt M; Gunawan B; Vingron M; Füzesí L; Poustka A
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):646-55. PubMed ID: 15701852
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of renal cell carcinoma.
Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
[TBL] [Abstract][Full Text] [Related]
15. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
[TBL] [Abstract][Full Text] [Related]
16. Advances in molecular classification of renal neoplasms.
Yin-Goen Q; Dale J; Yang WL; Phan J; Moffitt R; Petros JA; Datta MW; Amin MB; Wang MD; Young AN
Histol Histopathol; 2006 Mar; 21(3):325-39. PubMed ID: 16372253
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
18. Potential role of genetic markers in the management of kidney cancer.
Junker K; Ficarra V; Kwon ED; Leibovich BC; Thompson RH; Oosterwijk E
Eur Urol; 2013 Feb; 63(2):333-40. PubMed ID: 23040205
[TBL] [Abstract][Full Text] [Related]
19. [Papillary renal cell carcinoma and tumor biology. A multicenter project with "tissue microarray" (TMA)].
Herrmann E; Wülfing C; Hartmann A
Urologe A; 2007 Sep; 46(9):1175-6. PubMed ID: 17646959
[No Abstract] [Full Text] [Related]
20. Prognostic factors and molecular markers for renal cell carcinoma.
Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
